The German Cancer Research Center (DKFZ) is one of Europe’s largest cancer research centers. “Research for a life without cancer" is the mission of our world-class scientists and all our team members.
The DKFZ is a place where the brightest minds pursue bold ideas and seek answers to pioneering scientific questions through collaboration, innovation, and exploration across many disciplines. We provide a dynamic environment that empowers excellence with state-of-the-art technologies, cutting-edge infrastructure, and a global scientific network.
Contribute your knowledge, vision, and dedication to create a space where scientific discovery in cancer research is transformed into benefits for human health.
With the German Cancer Research Center as its core center, the German Cancer Consortium (DKTK) brings together, on a long-term basis, outstanding partners from university medicine as well as other leading research institutions at eight sites across Germany. The DKTK conducts pioneering translational cancer research, educates the next generation of translationally oriented scientists, and establishes high-performance structures to facilitate the transfer of research findings into clinical cancer research and into industry. Further information can be found at dktk.dkfz.de.
The DKTK partner site Berlin is located at Charité – Universitätsmedizin Berlin and closely aligned with the Berlin Institute of Health (BIH) and Max Dellbrück Centre for Molecular Medicine (MDC). A major research focus is molecular diagnostics in the tissue-to-fluid continuum for precision intervention. In the research area Cancer Liquid Biopsy, we develop and provide patient-centric, nucleic acid-based molecular tools for diagnosis and longitudinal monitoring of cancer. We employ short- and long-read sequencing technologies and AI-powered analysis tools to study genomic, epigenomic, and transcriptomic readouts. While our methods are tumor type-agnostic by design, current projects focus on brain tumors, head-and-neck cancer, and hematolymphoid malignancies.
To support the development of patient-centric molecular diagnostic tools at the DKTK partner site Berlin, we are seeking for the next possible date an experienced
Reference number: 2026-0036
Located in the Department of Neuropathology at Charité, you will work in a collaborative, multidisciplinary environment with project partners in the Department of Oncology, Pediatric Oncology, and Radiation Oncology.
The successful candidate will be employed at DKFZ Heidelberg and physically located at a closely collaborating clinical department / institute at Charité – Universitätsmedizin Berlin.
Are you passionate about bioinformatics and eager to work in an interdisciplinary team? In our group, you will work on the following tasks:
The application (English or German) shall include a CV, a letter of motivation, degree certificates, and names and contact information of at least two references.
Contact:
Tobias Kraski
Phone: +49 30 450 564 656
The position is initially limited to 2 years with the possibility of prolongation.
Application Deadline: 27.03.2026
Applications by e-mail cannot be accepted.
Please also note that we cannot return applications submitted by post.
Then become part of the DKFZ and join us in contributing to a life without cancer!
Apply nowWe are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.
Share this job!
Deutsches Krebsforschungszentrum | Im Neuenheimer Feld 280 | 69120 Heidelberg | www.dkfz.de